IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Immunocellular Therapeutics

CUSIP: 452536105 | 94 institutional holders

Quarters

Q1 2017Q4 2016Q3 2016Q2 2016Q1 2016
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2017

D'Orazio & Associates, Inc.75
0.0% of portfolio›$0
StyleTurnoverLocationFiled
D'Orazio & Associates, Inc.
75$00.0%ETFLowVienna, VA2017-05-16